Corcept Therapeutics (CORT) Treasury Shares (2013 - 2026)

Corcept Therapeutics (CORT) has 9 years of Treasury Shares data on file, last reported at $976.7 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 31.15% year-over-year to $976.7 million; the trailing twelve-month figure through Mar 2026 stood at $976.7 million (up 31.15% YoY), and the FY2025 full-year result was $966.6 million, up 38.84% from the prior year.
• Treasury Shares climbed to $976.7 million in Q1 2026, from $966.6 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $36.0 million in Q3 2025 to a low of $100000.0 in Q2 2023.
• A 4-year average of $13.6 million and a median of $1.6 million in 2025 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares jumped 216.6% in 2022 and grew 5.97% in 2024, its largest moves.
• Tracing CORT's Treasury Shares over 5 years: stood at $456.1 million in 2022, then jumped by 39.23% to $635.1 million in 2023, then increased by 9.62% to $696.2 million in 2024, then soared by 38.84% to $966.6 million in 2025, then increased by 1.05% to $976.7 million in 2026.
• Business Quant data shows CORT's Treasury Shares at $976.7 million in Q1 2026, $966.6 million in Q4 2025, and $923.3 million in Q3 2025.